What's breaking now, across thousands of outlets.
Plus, news about Novartis. 🤝 Pfizer turns over ADC: The New York pharma is giving Medicus Pharma co-development rights to a CD228-targeted antibody-drug conjugate known as PF-08046031, a Seagen-derived asset that it ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
IfeanHealth and Stanbic IBTC’s Together4ALimb program has provided prosthetic limbs and educational support to 250 beneficiaries in Nigeria, restoring mobi Read More…
IfeanHealth and Stanbic IBTC’s Together4ALimb program has provided prosthetic limbs and educational support to 250 beneficiaries in Nigeria, restoring mobi Read More…
A breakthrough drug recently approved to treat advanced pancreatic cancer may show promise against lung cancer as well, a new study suggests.
Bone and joint infections cause significant health problems for patients and lead to millions of dollars in added health costs per year, but clinicians lack reliable tools to predict which patients…
(MedPage Today) -- Thomas Steffens, DO, the Colorado surgeon accused of shooting at federal agents who were trying to arrest him in Florida, has been indicted on multiple charges, including attempted…
Dr. Lal should hold discussions with various State-level agencies and officials, study the health sector issues in depth, and submit an interim report with his observations and recommendations to the…
